News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
522,427 Results
Type
Article (44646)
Company Profile (130)
Press Release (477651)
Section
Business (145393)
Career Advice (2393)
Deals (28007)
Drug Delivery (113)
Drug Development (68050)
Employer Resources (149)
FDA (15597)
Job Trends (11971)
News (264335)
Policy (29647)
Tag
Academia (2307)
Alliances (36027)
Alzheimer's disease (1316)
Approvals (15531)
Artificial intelligence (135)
Bankruptcy (302)
Best Places to Work (9177)
Breast cancer (177)
Cancer (1321)
Cardiovascular disease (111)
Career advice (1997)
CAR-T (97)
Cell therapy (278)
Clinical research (54341)
Collaboration (419)
Compensation (270)
COVID-19 (2562)
C-suite (101)
Data (1293)
Diabetes (178)
Diagnostics (5143)
Drug pricing (104)
Earnings (57383)
Employer resources (137)
Events (75480)
Executive appointments (353)
FDA (16287)
Funding (362)
Gene therapy (209)
GLP-1 (674)
Government (3811)
Healthcare (14808)
Infectious disease (2657)
Inflammatory bowel disease (105)
Interviews (445)
IPO (13881)
Job creations (3169)
Job search strategy (1664)
Layoffs (459)
Legal (6940)
Lung cancer (196)
Lymphoma (99)
Manufacturing (200)
Medical device (11115)
Medtech (11118)
Mergers & acquisitions (14295)
Metabolic disorders (501)
Neuroscience (1637)
NextGen Class of 2024 (4987)
Non-profit (3177)
Northern California (1581)
Obesity (293)
Opinion (195)
Patents (121)
People (42166)
Phase I (16225)
Phase II (23519)
Phase III (19342)
Pipeline (515)
Postmarket research (2217)
Preclinical (6567)
Radiopharmaceuticals (202)
Rare diseases (269)
Real estate (4289)
Regulatory (20419)
Research institute (2064)
Resumes & cover letters (402)
Southern California (1316)
Startups (2749)
United States (13521)
Vaccines (636)
Weight loss (233)
Date
Last 7 days (166)
Last 30 days (1588)
Last 365 days (30838)
2025 (92)
2024 (31472)
2023 (35045)
2022 (45175)
2021 (48620)
2020 (45644)
2019 (36391)
2018 (27534)
2017 (27909)
2016 (25933)
2015 (28123)
2014 (21907)
2013 (17896)
2012 (19115)
2011 (19537)
2010 (17671)
Location
Africa (674)
Arizona (141)
Asia (30783)
Australia (5387)
California (3454)
Canada (1102)
China (251)
Colorado (154)
Connecticut (183)
Europe (74866)
Florida (503)
Georgia (116)
Illinois (309)
Indiana (176)
Maryland (595)
Massachusetts (2677)
Michigan (135)
Minnesota (240)
New Jersey (1014)
New York (956)
North Carolina (680)
Northern California (1581)
Ohio (119)
Pennsylvania (823)
South America (1038)
Southern California (1316)
Texas (489)
Washington State (362)
522,427 Results for "dompe u s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BIOSECURE Act
WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow
WuXi AppTec looks to unload its Philadelphia manufacturing sites and WuXi Biologics slows its rapid expansion in the U.S. as the companies await the Senate’s review of the BIOSECURE Act that threatens to cut them off from U.S. biopharma.
October 8, 2024
·
5 min read
·
Ben Hargreaves
Opinion
BIOSECURE Act Threatens Already Strained U.S. Supply Chain
As Congress considers a bill that aims to distance U.S. biopharma from five Chinese companies, the industry must emphasize the importance of prioritizing patient care over power plays.
September 9, 2024
·
3 min read
·
JX (Jaxon) Tan
Podcast
A Tough Ending, New Beginnings and China-U.S. Biopharma Relations
Well-financed startup Tome is winding down operations just as two new companies, Borealis Biosciences and GondolaBio, are launching. Meanwhile, in the midst of already tense relations with China, House lawmakers raise the alarm about U.S. companies working with the country’s military on trials.
August 28, 2024
·
1 min read
·
Heather McKenzie
Press Releases
Glaukos Submits New Drug Application to U.S. FDA for Epioxa™
December 23, 2024
·
5 min read
Press Releases
Mesoblast’s RYONCIL® is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) Therapy
December 18, 2024
·
10 min read
Press Releases
PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen
November 13, 2024
·
3 min read
Press Releases
U.S. Telemedicine Market Size to Hit USD 160.45 Billion by 2034
January 2, 2025
·
1 min read
Press Releases
Pacira Awarded New U.S. Patent Covering EXPAREL Composition
December 4, 2024
·
7 min read
Press Releases
U.S. Pharmaceutical CDMO Market to Reach USD 83.86 Billion to 2034
December 23, 2024
·
1 min read
Press Releases
Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
December 9, 2024
·
3 min read
1 of 52,243
Next
